ReviewCell and tissue banking2026
Advancements in pediatric tissue engineering: scaffold-based and cell-driven approaches.
Review in Cell and tissue banking, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue engineering holds significant promise for advancing pediatric reconstructive surgery by overcoming the limitations of conventional autografts and static implants while harnessing the unique regenerative potential of developing tissues. This review aims to synthesize recent progress and ongoing challenges in pediatric tissue engineering, with a primary focus on the development, design, and clinical translation of biomaterial scaffolds. We examine how scaffold architecture, material composition, and fabrication strategies can be tailored to accommodate pediatric growth, dynamic mechanical demands, and long-term biological integration. While complementary approaches such as stem cell therapies, computational modeling, and disease-specific platforms are acknowledged, the central emphasis remains on scaffold-based solutions that address the distinct anatomical and physiological requirements of children. By moving beyond adult-centric treatment paradigms, the field is gradually shifting toward a more integrated regenerative surgery framework that prioritizes adaptive tissue remodeling and functional recovery. Ultimately, this review highlights how purpose-built scaffolds and emerging biofabrication techniques are paving the way for safer, more effective reconstructive options in pediatric care, while identifying the key translational and regulatory barriers that must be addressed to realize their full clinical potential.
Indexed as
Identifiers
42489939What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.